Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF-β Signaling Pathway Activation in Type 2 Diabetic Rats

Figure 8

The inhibition of PUR on TGF-β induced Smad2/3 signaling pathway activation. (a) Immunohistochemical staining of TGF-β, magnified by 400x. (b) Quantitative results of TGF-β staining assessed by ImageJ. Data are presented as , per group. (c) Western blot analysis for TGF-β protein expression and phosphate Smad2/3 in liver tissue. Data are presented as , per group, replicated twice. , , and compared versus DM.

(a)

(b)

(c)